• Issue

    Pigment Cell & Melanoma Research: Volume 35, Issue 2

    i, 185-284
    March 2022
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

COVER IMAGE

Free Access

Cover Image

  • Page: i
  • First Published: 28 February 2022
Cover Image Volume 35 Issue 2, 2022

The cover image was provided by George Beschen, Courtesy of Fox Chase Cancer Center.

ISSUE INFORMATION - TOC

Free Access

Issue Information

  • Pages: 185-189
  • First Published: 28 February 2022

OBITUARY

Free Access

In memoriam Beatrice Mintz (1921–2022)

Lionel Larue, 
  • Pages: 190-191
  • First Published: 28 February 2022

REVIEWS

Free Access

Eosinophils and melanoma: Implications for immunotherapy

India Robinson,  Gabriella Santa Lucia,  Andraia Li,  Nathaniel Oberholtzer,  John Plante,  Kristen M. Quinn,  Daniel Reuben,  Shikhar Mehrotra,  Manuel Valdebran, 
  • Pages: 192-202
  • First Published: 20 December 2021
Free Access

Artificial intelligence and melanoma: A comprehensive review of clinical, dermoscopic, and histologic applications

Katherine M. Stiff,  Matthew J. Franklin,  Yufei Zhou,  Anant Madabhushi,  Thomas J. Knackstedt, 
  • Pages: 203-211
  • First Published: 17 January 2022

ORIGINAL ARTICLES

Full Access

Impact of a SLC24A5 variant on the retinal pigment epithelium of a Japanese patient with oculocutaneous albinism type 6

Toru Saito,  Ken Okamura,  Rika Kosaki,  Kazumasa Wakamatsu,  Shosuke Ito,  Osamu Nakajima,  Hidetoshi Yamashita,  Yutaka Hozumi,  Tamio Suzuki, 
  • Pages: 212-219
  • First Published: 06 December 2021
Full Access

New insights into segmental vitiligo: A clinical and immunological comparison with nonsegmental vitiligo

Xinya Xu,  Min Jiang,  Chengfeng Zhang,  Zhuhui Qiao,  Wenjie Liu,  Yan Le,  Jiaqiang Wu,  Wenjuan Ma,  Leihong Flora Xiang, 
  • Pages: 220-228
  • First Published: 15 November 2021
Full Access

Molecular characterization of biphenotypic epithelioid and plexiform melanoma with deep penetrating nevus-like features

Alessio Giubellino,  Andrew C. Nelson,  Yuyu He,  Sarah A. Munro,  Kyu Young Song,  Isabella C. Glitza Oliva,  Carlos Torres-Cabala, 
  • Pages: 229-237
  • First Published: 11 October 2021
Full Access

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) sensitize melanoma cells to MEK inhibition and inhibit metastasis and relapse by inducing degradation of AXL

Yingshi Chen,  Yiwen Zhang,  Siqi Chen,  Weiwei Liu,  Yingtong Lin,  Hui Zhang,  Fei Yu, 
  • Pages: 238-251
  • First Published: 08 November 2021
Open Access

Ulcerated melanoma: Systems biology evidence of inflammatory imbalance towards pro-tumourigenicity

John Davies,  Sathya Muralidhar,  Juliette Randerson-Moor,  Mark Harland,  Sally O’Shea,  Joey Diaz,  Christy Walker,  Jérémie Nsengimana,  Jon Laye,  Tracey Mell,  May Chan,  Lizzie Appleton,  Sofia Birkeälv,  David J. Adams,  Graham P. Cook,  Graham Ball,  David T. Bishop,  Julia A. Newton-Bishop, 
  • Pages: 252-267
  • First Published: 26 November 2021

PERSPECTIVE

Open Access

Let’s talk about sex: A biological variable in immune response against melanoma

Panshak P. Dakup,  Adam J. Greer,  Shobhan Gaddameedhi, 
  • Pages: 268-279
  • First Published: 25 January 2022

LETTER TO THE EDITOR

Full Access

Prediagnostic serum 25-hydroxyvitamin D and leptin in relation to melanoma-specific death and overall death

Jo S. Stenehjem,  Nathalie C. Støer,  Reza Ghiasvand,  Tom K. Grimsrud,  Ronnie Babigumira,  Judy R. Rees,  Lill Tove Nilsen,  Bjørn Johnsen,  Per M. Thorsby,  Marit B. Veierød,  Trude E. Robsahm, 
  • Pages: 280-284
  • First Published: 02 January 2022